Skip to main
SHC

Sotera Health (SHC) Stock Forecast & Price Target

Sotera Health (SHC) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Sotera Health is strongly positioned for growth, with its Sterigenics segment generating maximum revenue and all three segments showing strong performance in the recent quarter. With a focus on ensuring safety in healthcare products and a solid track record of consistent quarterly execution, the company is well-positioned to continue its upward trajectory in the future. Moreover, with a recent CEO succession plan that has been well-organized and an expected uptick in demand in the second half of the year, as well as potential for upward revision to guidance, we believe SHC is a strong investment opportunity with a target price of $25 per share in the near term.

Bears say

Sotera Health is facing uncertainty and potential challenges under its new CEO, as evident from the emphasis on continuity and a strategic planning process to address leverage and liquidity concerns. Accelerating growth on both organic and inorganic fronts will be a key focus, but this could put financial pressure on the company.

Sotera Health (SHC) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sotera Health (SHC) Forecast

Analysts have given Sotera Health (SHC) a Buy based on their latest research and market trends.

According to 7 analysts, Sotera Health (SHC) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sotera Health (SHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.